• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Detection of circulating heparin in cancer patients after port flush of indwelling venous access devices: implications for bevacizumab-associated thrombosis.

作者信息

Amirkhosravi Ali, Meyer Todd, Hatfield Meghan, Desai Hina, Amaya Mildred, Drexler Alane, Reyes Eduardo, Barranco John, Rathmann Kristin, Bigsby Glenn, Francis John L

出版信息

Blood Coagul Fibrinolysis. 2012 Mar;23(2):176-7. doi: 10.1097/MBC.0b013e32834eb972.

DOI:10.1097/MBC.0b013e32834eb972
PMID:22270797
Abstract
摘要

相似文献

1
Detection of circulating heparin in cancer patients after port flush of indwelling venous access devices: implications for bevacizumab-associated thrombosis.留置静脉通路装置端口冲洗后癌症患者循环肝素的检测：对贝伐单抗相关血栓形成的影响
Blood Coagul Fibrinolysis. 2012 Mar;23(2):176-7. doi: 10.1097/MBC.0b013e32834eb972.
2
Indwelling central venous access port insertion during bevacizumab-based therapy.贝伐珠单抗治疗期间留置中央静脉通路港的插入。
Anticancer Drugs. 2010 Aug;21(7):704-7. doi: 10.1097/CAD.0b013e32833a5c51.
3
Does low-dose heparin maintain central venous access device patency?: a comparison of heparin versus saline during a period of heparin shortage.低剂量肝素能否维持中心静脉置管通畅？：在肝素短缺期间肝素与生理盐水的比较。
JPEN J Parenter Enteral Nutr. 2010 Jul-Aug;34(4):444-9. doi: 10.1177/0148607110362082.
4
[Complications associated with the placement of subcutaneous central venous access port devices: reasons for removal and complications observed].[皮下中心静脉通路端口装置置入相关并发症：移除原因及观察到的并发症]
Gan To Kagaku Ryoho. 2012 Nov;39(12):2404-6.
5
Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer.癌症患者皮下植入式端口护理中预防性肝素冲洗间隔时间延长对维持其护理的影响
Eur J Cancer Care (Engl). 2009 Mar;18(2):191-4. doi: 10.1111/j.1365-2354.2008.00973.x.
6
Central venous port system-related complications in outpatient chemotherapy for colorectal cancer.
Hepatogastroenterology. 2012 Jun;59(116):1079-80. doi: 10.5754/hge09283.
7
Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapy.贝伐珠单抗治疗的 266 例乳腺癌患者中植入式静脉通路装置置管后的伤口愈合和导管血栓形成。
Anticancer Drugs. 2011 Nov;22(10):1020-3. doi: 10.1097/CAD.0b013e328349c7bb.
8
Bevacizumab recommendation highlights difficulties.贝伐单抗的推荐凸显了困难。
Cancer. 2011 Nov 15;117(22):5025. doi: 10.1002/cncr.26642.
9
Retrobulbar optic neuritis in a bevacizumab-treated patient with metastatic breast cancer.一名接受贝伐单抗治疗的转移性乳腺癌患者发生球后视神经炎。
Breast J. 2012 Sep;18(5):502-3. doi: 10.1111/j.1524-4741.2012.01293.x. Epub 2012 Aug 15.
10
Bevacizumab: overview of the literature.贝伐珠单抗：文献综述。
Expert Rev Anticancer Ther. 2012 May;12(5):567-80. doi: 10.1586/era.12.13.

引用本文的文献

1
Increased incidence of chemoport-related thrombosis in patients with colorectal cancer receiving bevacizumab: A single-institutional experience.接受贝伐单抗治疗的结直肠癌患者中化疗端口相关血栓形成的发生率增加：单机构经验。
Chin J Cancer Res. 2018 Aug;30(4):460-467. doi: 10.21147/j.issn.1000-9604.2018.04.09.